We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+30%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.29B
AUM Growth
+$370M
Cap. Flow
+$32.1M
Cap. Flow %
2.48%
Top 10 Hldgs %
19.69%
Holding
198
New
29
Increased
74
Reduced
24
Closed
25

Top Buys

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$20.7M
2
AVTR icon
Avantor
AVTR
+$14.9M
3
TGTX icon
TG Therapeutics
TGTX
+$13.5M
4
CELL
PhenomeX Inc. Common Stock
CELL
+$11.4M
5
TXG icon
10x Genomics
TXG
+$10.3M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$20.9M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$17.8M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$10.4M
4
PEN icon
Penumbra
PEN
+$10.1M
5
TWST icon
Twist Bioscience
TWST
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.02%
2 Technology 12.16%
3 Consumer Discretionary 8.78%
4 Industrials 6.66%
5 Financials 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPLI
76
People Inc
PPLI
$3.1B
$4.69M 0.36%
45,412
+3,809
+9% +$292K
TSM icon
77
TSMC
TSM
$2.18T
$4.63M 0.36%
42,496
+33,352
+365% +$3.16M
STKL
78
DELISTED
SunOpta
STKL
$4.62M 0.36%
395,647
+253,561
+178% +$2.23M
VICI icon
79
VICI Properties
VICI
$29.4B
$4.58M 0.35%
+179,500
New +$4.46M
DOW icon
80
Dow Inc
DOW
$21.2B
$4.44M 0.34%
+80,000
New +$4.13M
BBY icon
81
Best Buy
BBY
$17.3B
$4.44M 0.34%
44,467
-2,630
-6% -$294K
ABBV icon
82
AbbVie
ABBV
$435B
$4.29M 0.33%
+40,000
New +$3.84M
MSFT icon
83
Microsoft
MSFT
$3.71T
$4.21M 0.33%
18,920
+309
+2% +$66.4K
FITB
84
Fifth Third Bancorp
FITB
$51.8B
$4.14M 0.32%
+150,000
New +$3.79M
TEAM icon
85
Atlassian
TEAM
$37.8B
$4.04M 0.31%
17,294
+1,331
+8% +$281K
MA icon
86
Mastercard
MA
$493B
$3.95M 0.31%
11,066
+2,394
+28% +$796K
MTCH icon
87
Match Group
MTCH
$8.55B
$3.94M 0.3%
26,084
– –
ALXO icon
88
ALX Oncology
ALXO
$290M
$3.8M 0.29%
+44,032
New +$2.65M
AYX
89
DELISTED
Alteryx Inc
AYX
$3.79M 0.29%
31,104
+8,690
+39% +$1.1M
PLMR icon
90
Palomar
PLMR
$3.45B
$3.75M 0.29%
42,192
-14,259
-25% -$1.2M
CSGP icon
91
CoStar Group
CSGP
$12.3B
$3.72M 0.29%
40,200
+3,240
+9% +$284K
ASML icon
92
ASML
ASML
$669B
$3.67M 0.28%
7,521
– –
APTV icon
93
Aptiv
APTV
$10.3B
$3.49M 0.27%
26,788
– –
CRNC icon
94
Cerence
CRNC
$413M
$3.44M 0.27%
34,218
-11,717
-26% -$874K
AAPL icon
95
Apple
AAPL
$4.57T
$3.36M 0.26%
25,347
– –
RDS.B
96
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$3.36M 0.26%
+100,000
New +$2.98M
DIS icon
97
Walt Disney
DIS
$181B
$3.35M 0.26%
18,502
+6,747
+57% +$968K
BA icon
98
Boeing
BA
$185B
$3.34M 0.26%
+15,602
New +$3M
TREX icon
99
Trex
TREX
$5.01B
$3.33M 0.26%
39,754
-62,198
-61% -$4.76M
DKNG icon
100
DraftKings
DKNG
$11.9B
$3.29M 0.25%
70,637
+24,130
+52% +$1.15M
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Nicholas Investment Partners held 198 positions worth $1.29B, up 40% from $925M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Investment Partners's Q4 2020 filing shows 29 new, 74 increased, 24 reduced and 25 closed positions. Its largest new stake was Arena Pharmaceuticals Inc: 276,633 shares worth $21.3M. The largest sale was Immunomedics Inc, an estimated $20.9M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Nicholas Investment Partners's largest Q4 2020 buy was Arena Pharmaceuticals Inc: 276,633 shares worth $21.3M.
  • Nicholas Investment Partners added most to TG Therapeutics in Q4 2020, an estimated $13.5M increase.
  • Nicholas Investment Partners's biggest Q4 2020 reduction was Twist Bioscience, cutting an estimated $10.1M.
  • Nicholas Investment Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.9M.
  • Nicholas Investment Partners's ten largest holdings make up 20% of its $1.29B portfolio in Q4 2020.
  • Nicholas Investment Partners opened 29 new positions and closed 25 in Q4 2020.
  • Nicholas Investment Partners's portfolio value rose 40% quarter-over-quarter to $1.29B.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.